73 results
6-K
EX-99.1
OBSVF
ObsEva SA
1 Jun 21
ObsEva SA Announces that Shareholders Approved all Board Proposals at its
6:30am
in the Investors / General Meetings section of the company’s website www.ObsEva.com
To access the general meetings section of the Company’s website … , please click here.
To access the AGM 2021 section of the general meetings section directly, please click here.
To access the full invitation to the AGM
6-K
EX-99.1
OBSVF
ObsEva SA
19 May 22
ObsEva SA Announces that Shareholders Approved all Board Proposals at its
7:05am
in the Investors / General Meetings section of the company’s website www.ObsEva.com.
To access the general meetings section of the Company’s website … , please click here.
To access the AGM 2022 section of the general meetings section directly, please click here.
To access the full invitation to the AGM
DRS
EX-10
OBSVF
ObsEva SA
14 Oct 16
Draft registration statement
12:00am
by a specialised firm or by the lessor.
The tenant undertakes to allow unrestricted access to the persons in charge of the metre readings and maintenance … access in its absence and will immediately inform the lessor or its representative of this.
If, for any reason whatsoever, the statement appears
F-1
EX-10.4
OBSVF
ObsEva SA
30 Dec 16
Registration statement (foreign)
12:00am
by a specialised firm or by the lessor.
The tenant undertakes to allow unrestricted access to the persons in charge of the metre readings and maintenance … access in its absence and will immediately inform the lessor or its representative of this.
If, for any reason whatsoever, the statement appears
6-K
OBSVF
ObsEva SA
17 May 22
Index to Unaudited Condensed Consolidated Financial Statements
7:00am
. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access … unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is possible that the ACA will be subject
6-K
EX-99.3
mrp0kbfkv1ful vwlr
7 Nov 19
Current report (foreign)
9:11am
6-K
EX-99.1
8lt6k6
5 Mar 21
ObsEva Announces Year End 2020 Financial Results
7:21am
6-K
EX-99.1
czc169ve
31 Mar 22
ObsEva Annual Report 2021
7:05am
6-K
min lygip3qv410q8
1 Dec 22
Index to Unaudited Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.3
oozru381a ta1
17 May 22
Index to Unaudited Condensed Consolidated Financial Statements
7:00am
6-K
EX-99.2
uvddu
22 Nov 21
Obseva Announces U.S. FDA Acceptance of New Drug Application for Linzagolix
6:05am
6-K
EX-99.1
oejahdshgd8ah8ax0
7 Aug 19
Current report (foreign)
7:21am
6-K
j5mvj
25 Jul 18
Current report (foreign)
8:21am
6-K
EX-99.1
66l24jqxm402ch2pi8
4 Jun 20
ObsEva Announces Publication of Data Showing Efficacy of Linzagolix in a Potential New Indication for Treatment of Adenomyosis
6:11am
6-K
EX-1.1
c0axca7
5 Mar 21
Current report (foreign)
8:15am
F-1
EX-10.1
lrziu0fd0935ppc
30 Dec 16
Registration statement (foreign)
12:00am
6-K
EX-99.1
ja4kn v11a
7 Apr 22
ObsEva Annual General Meeting 2022
7:01am
6-K
zehg1d
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
10-K
5s6na2pm8yh06g1gt6qz
31 Mar 23
Annual report
4:01pm
DRS
EX-10
wtors xijy
14 Oct 16
Draft registration statement
12:00am